Patent directory · USPTO A61K / A61P
Patents matching “INSTITUT DE CANCEROLOGIE DE L'OUEST”
4 pharma patents match "INSTITUT DE CANCEROLOGIE DE L'OUEST" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Matches 4
Index total 30,257
Page 1 / 1
Quick answer
This filtered view shows 4 pharmaceutical patents matching "INSTITUT DE CANCEROLOGIE DE L'OUEST" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11697689
Use of antibody against O-acetylated GD2 ganglioside to improve the therapeutic potential of drugs
granted -
US 10307410
Mcl-1 modulating compounds for cancer treatment
granted -
US 9523691
Use of the olfactomedin-4 protein (OLFM4) in colorectal cancer diagnosis
granted -
US 9463193
Individual 5-fluorouracile dose optimization in folfiri treatment
granted